Analyst Reco. Elutia Inc.

Equities

ELUT

US05479K1060

Delayed Nasdaq Other stock markets 07:00:00 29/04/2024 pm IST			5-day change	1st Jan Change
2.87 ^USD	+3.24%		-1.71%	+32.87%

07/03	Transcript : Elutia Inc., Q4 2023 Earnings Call, Mar 07, 2024
07/03	Elutia Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Cuts Elutia's Price Target to $6 From $8, Keeps Overweight Rating	14/11	MT
Lake Street Initiates Elutia at Buy Rating With $3 Price Target	28/23/28	MT
Equity Futures Trend Higher as Investors Expect No Rate Hike From Fed	19/23/19	MT
Cantor Fitzgerald Trims Price Target on Aziyo Biologics to $10 From $12, Maintains Overweight Rating	12/23/12	MT
Turist Securities Adjusts Aziyo Biologics Price Target to $10 From $8, Maintains Buy Rating	16/22/16	MT
Piper Sandler Adjusts Price Target on Aziyo Biologics to $10.50 From $9, Maintains Overweight Rating	15/22/15	MT
Cowen Adjusts Aziyo Biologics' Price Target to $13 From $15, Keeps Outperform Rating	04/22/04	MT
Piper Sandler Adjusts Aziyo Biologics' Price Target to $9 From $11, Reiterates Overweight Rating	04/22/04	MT
Piper Sandler Adjusts Aziyo Biologics' Price Target to $11 From $14, Reiterates Overweight Rating	10/21/10	MT
AZIYO BIOLOGICS : Piper Sandler Adjusts Aziyo Biologics PT to $14 From $20, Maintains Overweight Rating	07/21/07	MT
AZIYO BIOLOGICS : Cantor Fitzgerald Starts Aziyo Biologics at Overweight With $20 Price Target	02/20/02	MT
AZIYO BIOLOGICS : Cowen Starts Aziyo Biologics at Outperform With $20 Price Target	02/20/02	MT
AZIYO BIOLOGICS : Truist Securities Starts Aziyo Biologics at Buy With $20 Price Target	02/20/02	MT
AZIYO BIOLOGICS : Piper Sandler Starts Aziyo Biologics at Overweight With $20 Price Target	02/20/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer